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Although hypercalcemia is a known metabolic complication of sarcoidosis, it is rarely a presenting manifestation. Long-standing
hypercalcemia and hypercalciuria can cause nephrocalcinosis and chronic renal failure. Acute renal failure, although described,
is also a rare presentation of patients with sarcoidosis. We describe two patients with sarcoidosis, who presented with severe
hypercalcemia and worsening renal function. Parathyroid hormone levels were appropriately suppressed. This led to an extensive
search for the cause of hypercalcemia. Finally, after a lymph node biopsy in both cases, a diagnosis of sarcoidosis was established,
hypercalcemia resolved, and renal function improved in both cases after administration of prednisone.
1.Introduction
Although hypercalcemia is a known metabolic complication
of sarcoidosis, it is rarely a presenting manifestation. Hyper-
calciuria is the most common defect of calcium metabolism
with a prevalence of 50–62% [1–3]. Although hypercalcemia
in 11% and renal calculi in 10% of patients with sarcoidosis
has been reported [4], clinically signiﬁcant hypercalcemia is
lessfrequentand isgenerallyasymptomatic, occurring in less
than 5% of patients [5]. Persistent untreated hypercalcemia
andhypercalciuriacanleadtonephrocalcinosis,renalcalculi,
and renal failure [6]. We report two cases of sarcoidosis,
where the initial presentation was markedly elevated serum
calcium levels and acute renal failure, which presented a
diagnostic challenge.
2.Case 1
A 56-year-old Caucasian male was admitted three times
to the hospital in 3 months for recurrent abdominal
pain. He described it as an intermittent cramping pain,
located in the epigastrium, with some radiation to the left
lower quadrant. He also experienced intermittent nausea,
vomiting, and watery diarrhea. The pain was aggravated by
lying in supine position and improved with sitting upright.
He denied having any fever, chills, or any other associated
symptoms. He also noted excessive thirst and increased in
urination but denied dysuria or hematuria. He was found
to have persistent hypercalcemia and renal insuﬃciency
(see Table 1). A review of his medical record revealed that he
had been admitted to thehospital twiceduring the preceding
two months with similar symptomatology. Each time he
was noted to have hypercalcemia (serum calcium 13.3
and 13.5mg/dL, resp.) and acute renal insuﬃciency (BUN
44mg/dL and creatinine 2.1mg/dL). Serum and urine pro-
tein electrophoresis were negative. 1,25-dihydroxyvitamin
D level was 69ng/mL (reference range 22–67ng/mL), and
a simultaneously obtained PTH level was 6.9pg/mL (ref-
erence range 14–72pg/mL). His past medical history was
only signiﬁcant for nephrolithiasis. He was not taking
any medications regularly. Physical examination revealed
blood pressure of 129/80mmHg, heart rate 80/min regular.2 Case Reports in Medicine
Figure 1: CT Chest showing mediastinal lymphadenopathy.
He was febrile and did not appear to be in acute distress.
His cardiopulmonary exam was unremarkable. Abdominal
exam revealed mild tenderness in the epigastrium area and
left lower quadrant without any signs of guarding or rigidity.
Bowel sounds were active. Acute abdominal series X-ray
did not show any acute process. Laboratory investigation
showed normal CBC and urine analysis. Peak serum calcium
was 13.5mg/dL (reference range 8–10mg/dL), and ionized
calcium was elevated at 1.68mmol/L (reference range 1.10–
1.30mmol/L). Serum creatinine level was 3.4mg/dL (0.5–
1.4mg/dL). 1,25-dihydroxyvitamin D levels were elevated
and parathyroid hormone (PTH) levels were appropriately
suppressed (see Table 1). Serum angiotensin converting
enzyme level was elevated at 98units/L (reference range 8–
52units/L). He was treated with intravenous ﬂuid hydration
and loop diuretic while the etiology of hypercalcemia was
being sought, including an extensive investigation for occult
malignancy and granulomatous diseases. Chest X-ray was
normal. CT scans of chest, abdomen, and pelvis were
performed. Bone scan was unremarkable. CT Chest revealed
subtle mediastinal adenopathy (Figure 1), and subsequent
biopsy (Figures 2(a) and 2(b))c o n ﬁ r m e dt h ed i a g n o s i s
of sarcoidosis. Corticosteroid therapy was initiated and
hypercalcemia eventually resolved, and renal function also
improved (BUN 32, creatinine 1.8mg/dL).
3.Case 2
A 59-year-old Caucasian female was incidentally noted to
have hypercalcemia and elevated blood pressure during
routine outpatient labs screening. She stated that she had
been feeling well. She denied any history of fatigue, nausea,
anorexia, constipation, muscle ache, or changes in sen-
sorium. She did not complain of polyuria or polydipsia.
However, she stated that she drank 32 to 44 ounces of water
duringthe dayas a matterofhabit. Shehad lost 25poundsof
weight within the past six months unintentionally. She had
a remote history of nephrolithiasis in 1960 and occasional
bilateral hip pain. She also gave a history of removal of a
skin lesion on the nose, which was reported as “benign.”
Table 1: Laboratory values of patients 1 and 2.
Normal
value
Patient
no.1
Patient
no.2
Calcium 8–10.5mg/dL 13.5mg/dL 13.3mg/dL
Ionized calcium 1.10–
1.30mmol/L 1.68mmol/L 1.66mmol/L
Serum creatinine 0.5–1.4mg/dL 3.4mg/dL 2.4mg/dL
BUN 6–23mg/dL 55mg/dL 32mg/dL
25 hydroxyvitamin
D 14–42ng/mL 22ng/mL 21ng/mL
1,25-
Dihydroxyvitamin
D
22–67ng/mL 69ng/L Not done
Alkaline
phosphatase 1–120U/L 44U/L 48U/L
Phosphorus 2.5–4.5mg/dL 3.4mg/dL 3.1mg/dL
Parathyroid
hormone 12–72pg/mL 9.1pg/mL 9.0pg/mL
PTHrP <0.2pmol/L <0.2pmol/L 0.4pmol/L
ACE level 8–52U/L 98U/L 71U/L
24◦ urinary
calcium 100–300mg/24◦ 1074 448 and 587∗
TSH 0.35–
5.50uIU/mL 1.80uIU/mL 2.8mIU/mL
CBC
HGB
12–15g/dL HGB 12.8g/dL HGB 9.9g/dL
HCT 36–45% HCT 34.6% HCT 29.4%
WBC 4–12 ×
103/mm3g/dL
WBC 5.6
×103/mm3
WBC 4.1
×103/mm3
Platelets
150–400g/dL
Platelets
132g/dL
Platelets
190g/dL
∗Measured on two diﬀerent occasions.
She denied taking any vitamin or other herbal supplements.
There was no family history of endocrine disorders. She had
no history of smoking tobacco, consuming alcohol, or use
of illicit drugs. She had not been taking any medications.
Physical examination revealed elevated blood pressure of
210/98mmHg that substantially came down to 146/86 with
treatment. Oral temperature was 99.4F (37.4◦C); pulse had
a regular rhythm with a rate of 80bpm. She was alert,
oriented, and did not appear to be in acute distress. Her
lungs were clear to auscultation with normal respiratory
eﬀort. A grade 2/6 systolic ejection murmur was heard over
left sternal border. Abdomen was soft and not tender to
palpation. Muscle strengths were normal and symmetrical in
all extremities. She was found to have normochromic nor-
mocyticanemiawithhemoglobinof9.9g/dL.Serumcalcium
level was noted to be persistently elevated over a period of 6
months with a peak level of 14.0mg/dL (range from 11.4 to
14.0mg/dL).Renal functionwasimpaired with a peakserum
creatinine of 2.4mg/dL (range 1.7–2.4mg/dL). BUN ranged
from 26 to 32mg/dL. 24 hours urine calcium was elevated
at 448mg and 587mg measured on two diﬀerent occasions
(reference range 100–300mg/ 24hr). Serum phosphate and
25 hydroxyvitamin D levels were within normal limitsCase Reports in Medicine 3
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Figure 2: (a) Lymph node biopsy (low power). (b) Lymph node
biopsy (high power).
Figure 3: CT Chest showing mediastinal lymphadenopathy.
(see Table 1). PTH level was appropriately suppressed and
PTH related peptide (PTHrP) was elevated. A diagnosis of
occult malignancy was suspected. Angiotensin-converting
enzyme (ACE) was elevated (see Table 1). Chest and spine
X-rays were negative as well as mammogram, bone marrow
biopsy, and bone scan. Extensive evaluation failed to reveal
malignancy. CT scan of the chest was performed as part of
a malignancy workup, and it showed borderline mediastinal
(a)
(b)
Figure 4: (a) Lymph node biopsy showing noncaseating granu-
lomatous change (low power). (b) Lymph node biopsy showing
noncaseating granulomatous change (high power).
adenopathy in the paraaortic and pretracheal area and
subcarinal region (Figure 3). Biopsy of the lymph nodes
conﬁrmed the diagnosis of sarcoidosis (Figures 4(a) and
4(b)). With steroid treatment, the hypercalcemia resolved
(Ca = 9.2mg/dL) and renal function also improved (BUN
21.3mg/dL, creatinine 0.8mg/dL).
4.Discussion
Hypercalcemia is a common clinical entity encountered
these days because of the routine multichannel chemistry
screening. The most common cause of hypercalcemia in the
outpatient clinic is primary hyperparathyroidism, whereas
malignancy is the most common cause of hypercalcemia
in hospitalized patients. Other causes of hypercalcemia,
including sarcoidosis, are relatively uncommon. Both of our
patients presented with markedly elevated serum calcium
levels(13.5and 13.3mg/dL),and there were no otherclinical
clues to suggest sarcoidosis as the diagnosis. Both patients
had appropriately suppressed PTH levels suggesting that
the cause of hypercalcemia was not parathyroid hormone
dependent. Patient 2 also had an elevated PTHrP which sug-
gested an increased likelihood for malignancy. Both patients
underwent an extensive, but futile search for malignancy.
Sarcoidosis is an idiopathic, multisystem, and granulo-
matous disease. It aﬀects people of all racial and ethnic
groups of all ages. Its peak incidence is between 20 and 394 Case Reports in Medicine
years. The incidence among African Americans is approxi-
mately three times than among white Americans and tends
to occur later in life [4].
The fundamental abnormality in sarcoidosis involves the
formation of immune granulomas in various organs. The
lung and the intrathoracic lymph nodes are the main organ
systems involved, but every organ may be aﬀected [7]. The
frequent extrathoracic involvement sites include peripheral
lymph nodes, eyes, skin, and liver, each being found in
approximately 10–25% of cases [7]. Sarcoidosis commonly
presents with the abnormalities detected on a chest X-
ray (8–60%), but the presentation may vary depending on
several factors such as age, sex, race, the duration of the
disease, and the sites of involvement. European popula-
tion is more likely to present asymptomatically or with
erythema nodosum, while symptomatic and multivisceral
presentations are common in African Americans. The initial
symptoms of presentation include respiratory symptoms in
30% cases, constitutional symptoms such as fatigue (27%),
weight loss (28%), fever (10–27%), and erythema nodosum
(3–44%)[7] .L o f g r e n ’ ss y n d r o m ei sa na c u t ef o r mo fd i s e a s e ,
consistingofarthritis, erythemanodosum,andbilateralhilar
adenopathy (9–34%) and presents diﬀerently in men and
women [4].
As mentioned above, although hypercalcemia occurs in
about 11% cases of sarcoidosis [4], clinically signiﬁcant
hypercalcemia is less common [6], and we believe even
rarer as the presenting feature. However, we were unable to
determine how often it is the presenting symptom. Similarly,
although acute renal failure as the presenting feature of
sarcoidosis has been described, it remains of rare occurrence
[8, 9].
The mechanism of hypercalcemia in sarcoidosis is not
completely understood. Normally, the levels of vitamin D
and its active metabolite 1,25-dihydroxyvitamin D play an
important role in the maintenance of serum CA++ levels.
Vitamin Disderivedeitherfromendogenousproduction
of vitamin D in the skin or by ingestion of vitamin D.
Vitamin D is hydroxylated to 25 hydroxyvitamin D in the
liver,which issubsequentlyconvertedto1,25-dihydroxy Din
the proximal renal tubules by the enzyme 1, α hydroxylase.
This enzyme is tightly regulated by parathyroid hormone
(PTH), serum calcium, and phosphorus levels [10].
In 1939, Harrell and Fisher reported the occurrence of
hypercalcemia in 6 of 11 patients with sarcoidosis [11]. On
subsequent studies, in 1979, Papapoulos et al. [12]a n dB e l l
et al. [13] were among the ﬁrst to recognize that levels
of 1,25-dihydroxyvitamin D are elevated in patients with
sarcoidosis. The high levels of 1,25-dihydroxyvitamin D are
the probable cause of hypercalcemia, but overproduction
of bone resorbing cytokines and PTHrP may also play a
role [14]. The level of PTHrP in one of our patients was
elevated, but in case 1 it was normal. Zeimer et al. described
two cases of sarcoidosis with hypercalcemia and elevated
PTHrP. They also demonstrated that in an archival study of
20 lymph node biopsies with the pathological diagnosis of
sarcoidosis, where immunohistochemical analysis detected
PTHrP in macrophages with granulomata in 17 out of 20
biopsies (85%) [14]. The renal 1, α hydroxylase is activated
by PTH and suppressed by 1,25-dihydroxyvitamin D [10].
Themacrophageenzymeisunaﬀectedbyanyofthesefactors.
Instead, one of its major trophic activators is cytokine
interferon gamma [15]. Lack of feedback in response to
increased levels of 1,25-dihydroxyvitamin D leads to an
enhanced calcium absorption in the small intestine and an
excessofboneresorptioninpatientswithsarcoidosis,leading
to hypercalcemia.
The diagnosis of sarcoidosis may be elusive, especially in
atypical populations, given the variation of the presentation
of the organs involved. Hypercalcemia may be a clue to the
diagnosis, especially in cases with no pulmonary symptoms
or ﬁndings on chest X-ray. Sarcoidosis should be consid-
ered in patients with hypercalcemia, low PTH levels, and
elevated calcitriol levels. As mentioned above, longstanding
hypercalcemiaandhypercalciuriacancausenephrocalcinosis
and renal failure [2, 6]. Although severe hypercalcemia is
rare in sarcoidosis [1, 5], patients may present with severe
hypercalcemia, associated with renal failure, as was the case
in our patients.
Treatment of hypercalcemia due to sarcoidosis is beyond
the scope of this paper. However, it has been reviewed by
Conron et al. [1]a n dS h a r m a[ 16] and is discussed here
only brieﬂy. Therapeutic options include rehydration, a loop
diuretic to promote calcium secretion, and corticosteroids
[1]. Corticosteroids have been the ﬁrst-line therapy in treat-
ing hypercalcemia associated with sarcoidosis because of
their eﬀectiveness in rapidly correcting hypercalcemia.
Prednisone in 20 to 40mg/day is the drug of choice to
reducetheendogenousproductionof1,25dihydroxyvitamin
D. Institution of steroids causes a relatively swift decrease
in circulating 1,25 dihydroxyvitamin D and serum calcium
levels in 3 to 5 days [16]. Patients with asymptomatic mild
hypercalcemia should be advised to avoid sun exposure and
vitamin D rich diet and maintain hydration of more than 2
liters per day. The role of avoiding dairy product and low
calcium diet is controversial since there is little evidence that
it aﬀects calcium balance [1].
Ketoconazole is an alternative for patients where the
steroid use is contraindicated. It inhibits the cytochrome
P450-linked enzyme systems involved in steroid synthesis
including 25(OH) D3-1a-hydroxylase [17]. Hydroxychloro-
quine also causes similar eﬀects and can be used in patients
who cannot tolerate ketoconazole or who develop abnormal
liver function tests [18]. Methotrexate and azathioprine may
also help control hypercalcemia by reducing the granuloma
formation [1].
5.Conclusion
We report two patients with sarcoidosis, where severe
hypercalcemia associated with acute renal failure was the
unusual presenting feature. It was only after extensive
investigation that a diagnosis of sarcoidosis was conﬁrmed.
Sarcoidosis without pulmonary symptoms may pose a
diagnostic challenge butshould besuspected in patientswith
nonparathyroid-dependent hypercalcemia. Timely recogni-
tion and appropriate treatment of hypercalcemia secondaryCase Reports in Medicine 5
to sarcoidosis should prevent development of nephrocalci-
nosis and renal failure.
Acknowledgments
The authors thank Jinie Shirey for preparing this paper and
James Richard, DOforhishelp with thepathology material.
References
[1] M. Conron, C. Young, and H. L. C. Beynon, “Calcium
metabolism in sarcoidosis and its clinical implications,”
Rheumatology, vol. 39, no. 7, pp. 707–713, 2000.
[ 2 ]A .R .B e r l i n e r ,M .H a a s ,a n dM .J .C h o i ,“ S a r c o i d o s i s :
the nephrologist’s perspective,” American Journal of Kidney
Diseases, vol. 48, no. 5, pp. 856–870, 2006.
[3] E. Lebacq, V. Desmet, and H. Verhaegen, “Renal involvement
in sarcoidosis,” Postgraduate Medical Journal, vol. 46, no. 538,
pp. 526–529, 1970.
[ 4 ]M .C .I a n n u z z i ,B .A .R y b i c k i ,a n dA .S .T e i r s t e i n ,“ S a r c o i d o -
sis,” New England Journal of Medicine, vol. 357, no. 21, pp.
2153–2108, 2007.
[5] R. L.Taylor, H.J.Lynch, andW.G. Wysor,“Seasonalinﬂuence
ofsunlightonthehypercalcemia ofsarcoidosis,”TheAmerican
Journal of Medicine, vol. 34, no. 2, pp. 221–227, 1963.
[6] R. S. Muther, D. A. McCarron, and W. M. Bennett, “Renal
manifestations of sarcoidosis,” Archives of Internal Medicine,
vol. 141, no. 5, pp. 643–645, 1981.
[ 7 ]H .N u n e s ,D .B o u v r y ,P .S o l e r ,a n dD .V a l e y r e ,“ S a r c o i d o s i s , ”
Orphanet Journal of Rare Diseases, vol. 2, no. 1, article no. 46,
2007.
[8] A. Awasthi, R. Nada, P. Malhotra,R. Goel, and K. Joshi,“Fatal
renal failure as the ﬁrst manifestationofsarcoidosisdiagnosed
on necropsy in a young man: a case report,” Journal of Clinical
Pathology, vol. 57, no. 10, pp. 1101–1103, 2004.
[9] C. Ponce and J. S. Gujral, “Renal failure and hypercalcemia as
initial manifestations of extrapulmonary sarcoidosis,” South-
ern Medical Journal, vol. 97, no. 6, pp. 590–592, 2004.
[10] M. F. Hollick, “Vitamin D deﬁciency,” New England Journal of
Medicine, vol. 357, pp. 266–281, 2007.
[11] G. T. Harrell andS.Fisher, “Bloodchemicalchanges inboeck’s
sarcoid with particular reference to protein, calcium and
phosphatase values,” The Journal of Clinical Investigation,v o l .
18, pp. 687–693, 1939.
[12] S. E. Papapoulos, L. J. Fraher, and T. L. Clemens, “1,25 Dihy-
droxycholecalciferol inthepathogenesisofthehypercalcaemia
of sarcoidosis,”Lancet, vol. 1, no. 8117, pp. 627–630, 1979.
[13] N.H.Bell, P.H.Stern,andE.Pantzer,“Evidencethatincreased
circulating 1,25-dihydroxyvitamin D is the probable cause
for abnormal calcium metabolism in sarcoidosis,” Journal of
Clinical Investigation, vol. 64, no. 1, pp. 218–225, 1979.
[ 1 4 ]H .J .Z e i m e r ,T .M .G r e e n a w a y ,J .S l a v i ne ta l . ,“ P a r a t h y r o i d -
hormone-related protein in sarcoidosis,” American Journal of
Pathology, vol. 152, no. 1, pp. 17–21, 1998.
[15] T. Monkawa, T. Yoshida, M. Hayashi, and T. Saruta, “Identi-
ﬁcation of 25-hydroxyvitamin D 1α-hydroxylase gene expres-
sion in macrophages,” Kidney International,v o l .5 8 ,n o .2 ,p p .
559–568, 2000.
[16] O. P. Sharma, “Hypercalcemia in granulomatous disorders: a
clinical review,” Current Opinion in Pulmonary Medicine,v o l .
6, no. 5, pp. 442–447, 2000.
[17] J. S. Adams, O. P. Sharma, M. M. Diz, and D. B. Endres,
“Ketoconazole decreases the serum 1,25-dihydroxyvitamin D
and calcium concentrationin sarcoidosis-associatedhypercal-
cemia,” Journal of Clinical Endocrinology and Metabolism,v o l .
70, no. 4, pp. 1090–1095, 1990.
[18] J.S.Adams, M.M.Diz, and O.P. Sharma,“Eﬀective reduction
in the serum 1,25-dihydroxyvitamin D and calcium concen-
tration in sarcoidosis-associated hypercalcemia with short-
course chloroquine therapy,” Annals of Internal Medicine,v o l .
111, no. 5, pp. 437–438, 1989.Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com